MedTrace Logo

Fibrates in Pediatric Cholestasis

NCT03586674 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2018-07-17

No results posted yet for this study

Summary

A study conducted to assess the effect of fibrates on pruritus and biochemical picture in pediatric patients with cholestatic liver diseases.

Conditions

  • Chronic Cholestasis

Interventions

DRUG

Lipanthyl

Tablet

DRUG

Ursogal

suspension

Sponsors & Collaborators

  • Hoda A. Atta

    lead OTHER_GOV

Principal Investigators

  • Tawhida Y Abdel Ghaffar, MD · ASU

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2018-06-01
Completion
2018-06-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03586674 on ClinicalTrials.gov